Tata India Pharma & Healthcare Fund vs UTI Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1296 Cr | ₹1097 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 28 Dec 2015 | 30 Jul 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | Nifty Pharma TRI | BSE Healthcare |
| Turn Over | 26.49% | 28% |
| Expense Ratio | 2.14 | 2.22 |
| Manager | Meeta Shetty | Kamal Gada |
| ISIN Code | INF277K016A9 | INF789F01695 |
| Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | 2.87% | 2.21% |
| 6 Month | 5.58% | 8.59% |
| 1 Year | 2.1% | 5.02% |
| 3 Year | 21.91% | 23.9% |
| 5 Year | 17.7% | 17.66% |
SIP Return Analysis
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | 1.96% | 1.21% |
| 1 Year | 8.61% | 9.23% |
| 3 Year | 20.94% | 23.43% |
| 5 Year | 18.6% | 19.51% |
Rolling Lumpsum Returns
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 9.76% | 11.94% |
| 3 Year | 18.6% | 16.4% |
| 5 Year | 15.32% | 14.62% |
Risk Management
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 16.05% | 15.78% |
| Sharp | 0.90% | 1.02% |
| Beta | 0.98% | 0.95% |
| Alpha | -0.49% | 1.53% |
Fund Managers
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Meeta Shetty | Kamal Gada |
| Total AUM | ₹17847 Cr | ₹870 Cr |
| Funds Managed | 5 | 1 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 4.14 | 4.01 |
| Large Cap | 25.14 | 22.4 |
| Mid Cap | 37.44 | 33.54 |
| Small Cap | 33.28 | 40.04 |
Sector Allocation
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 1.72 | 1.02 |
| Healthcare | 94.07 | 97.9 |
| Basic Materials | 2.64 | 1.07 |
| Financial Services | 1.58 | - |
Top Comparisons
SBI Corporate Bond Fund - Regular Plan - Growth
3Y Returns7.62%
Nippon India Corporate Bond Fund - Growth Plan - Growth Option
3Y Returns8.05%
ITI Banking and PSU Fund Regular - Growth
3Y Returns7.12%
HSBC Banking and PSU Debt Fund - Regular Growth
3Y Returns7.31%
ICICI Prudential Ultra Short Term Fund - Growth
3Y Returns7.2%
Nippon India Ultra Short Duration Fund- Growth Option
3Y Returns6.95%
ICICI Prudential Large & Mid Cap Fund - Growth
3Y Returns21.84%
INVESCO INDIA LARGE & MID CAP FUND - Growth
3Y Returns25.23%